Alcon AG (ALC)
78.98
-1.05
(-1.31%)
USD |
NYSE |
Dec 04, 16:00
78.56
-0.42
(-0.53%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 38.79B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -8.01% |
| Valuation | |
| PE Ratio | 37.53 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.858 |
| Price to Book Value | 1.757 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.3410 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.2373 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 35.96% |
Profile
| Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland. |
| URL | http://www.alcon.com |
| Investor Relations URL | https://investor.alcon.com/home/default.aspx |
| HQ State/Province | Geneve (Geneva) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Feb. 24, 2026 (est.) |
| Last Earnings Release | Nov. 11, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 14, 2025 |
Ratings
Profile
| Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland. |
| URL | http://www.alcon.com |
| Investor Relations URL | https://investor.alcon.com/home/default.aspx |
| HQ State/Province | Geneve (Geneva) |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Feb. 24, 2026 (est.) |
| Last Earnings Release | Nov. 11, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 14, 2025 |